SAFETY AND IMMUNOGENICITY OF MN AND IIIB RGP120/HIV-1 VACCINES IN HIV-1-INFECTED SUBJECTS WITH CD4 COUNTS GREATER-THAN-500 CELLS/MM(3)

被引：0

作者：

ALLAN, JD

MITSUYASU, R

LAVELLE, JP

CONANT, MA

TWADDELL, T

KAHN, JO

机构：

[1] NEW ENGLAND DEACONESS HOSP,AUDREY KENNEDY AMBULATORY CARE CTR 6,INFECT DIS CLIN,BOSTON,MA 02215

[2] UNIV CALIF LOS ANGELES,AIDS CLIN RES CTR,LOS ANGELES,CA 90024

[3] GEORGETOWN UNIV,MED CTR,WASHINGTON,DC 20007

[4] CONANT MED GRP,SAN FRANCISCO,CA 94115

[5] GENENTECH INC,S SAN FRANCISCO,CA 94080

[6] SAN FRANCISCO GEN HOSP,DIV AIDS ACTIVITIES,SAN FRANCISCO,CA 94110

来源：

AIDS RESEARCH AND HUMAN RETROVIRUSES | 1994年 / 10卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：S157 / S157

页数：1

共 50 条

[21] Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: Association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS
Panther, LA
Coombs, RW
Zeh, JE
Collier, AC
Corey, L
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (04): : 303 - 313
[22] CD4 T-CELL COUNTS AND ITS USE IN THE CARE OF HIV-1-INFECTED PATIENTS
REYESTERAN, G
DELEON, SP
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1993, 45 (04): : 363 - 370
[23] Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3
Pollard, RB
Peterson, D
Hardy, D
Pottage, J
Murphy, RL
Gathe, J
Beall, G
Rutkievicz, V
Reynolds, L
Cross, AP
Dunkle, LM
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 22 (01) : 39 - 48
[24] Trends in Post-Infection CD4 Cell Counts and Plasma HIV-1 RNA Levels in HIV-1-Infected Patients in France Between 1997 and 2005
Potard, Valerie
Weiss, Laurence
Lamontagne, Franck
Rouveix, Elisabeth
Beck-Wirth, Genevieve
Drogoul-Vey, Marie-Pierre
Souala, Mohamed Faouzi
Costagliola, Dominique
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (03) : 422 - 426
[25] Activation and lysis of human CD4 cells latently infected with HIV-1
Pegu, Amarendra
Asokan, Mangaiarkarasi
Wu, Lan
Wang, Keyun
Hataye, Jason
Casazza, Joseph P.
Guo, Xiaoti
Shi, Wei
Georgiev, Ivelin
Zhou, Tongqing
Chen, Xuejun
O'Dell, Sijy
Todd, John-Paul
Kwong, Peter D.
Rao, Srinivas S.
Yang, Zhi-yong
Koup, Richard A.
Mascola, John R.
Nabel, Gary J.
NATURE COMMUNICATIONS, 2015, 6
[26] Activation and lysis of human CD4 cells latently infected with HIV-1
Amarendra Pegu
Mangaiarkarasi Asokan
Lan Wu
Keyun Wang
Jason Hataye
Joseph P. Casazza
Xiaoti Guo
Wei Shi
Ivelin Georgiev
Tongqing Zhou
Xuejun Chen
Sijy O’Dell
John-Paul Todd
Peter D. Kwong
Srinivas S. Rao
Zhi-yong Yang
Richard A. Koup
John R. Mascola
Gary J. Nabel
Nature Communications, 6
[27] Plasma viral load, CD4(+) cell counts, and HIV-1 production by cells
Levy, JA
Ramachandran, B
Barker, E
Guthrie, J
Elbeik, T
SCIENCE, 1996, 271 (5249) : 670 - 671
[28] Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 legion
Kröpelin, M
Süsal, C
Daniel, V
Opelz, G
IMMUNOLOGY LETTERS, 1998, 63 (01) : 19 - 25
[29] Predominance of detrimental humoral immune responses to HIV-1 in AIDS patients with CD4 lymphocyte counts less than 400/mm(3)
McDougall, B
Nymark, MH
Landucci, G
Forthal, D
Robinson, WE
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1997, 45 (01) : 103 - 111
[30] The safety and antiviral effect of 1592U89, alone and in combination with zidovudine in HIV-1 infected patients with CD4+ counts 200-500 cells/mm(3)
Sonnerborg, A
Lancaster, D
Torres, R
Thompson, M
Saag, M
Schooley, R
Mulder, J
Gazzard, B
DAquila, R
Gurgul, M
Feinberg, J
Santin, M
Lang, W
Harrigan, PR
Steel, H
Tortell, S
Romero, C
AIDS, 1996, 10 : OP41 - OP41

← 1 2 3 4 5 →